Navigation Links
Genetic discovery points the way to much bigger yields in tomato, other flowering food plants
Date:12/26/2013

Cold Spring Harbor, NY Every gardener knows the look of a ripe tomato. That bright red color, that warm earthy smell, and the sweet juicy flavor are hard to resist. But commercial tomato plants have a very different look from the backyard garden variety, which can grow endlessly under the right conditions to become tall and lanky. Tomatoes that will be canned for sauces and juice are harvested from plants that stop growing earlier than classic tomato varieties, and are therefore more like bushes. While the architecture of these compact bushy plants allows mechanical harvesters to reap the crop, the early end of growth means that each plant produces fewer fruits than their home garden cousins.

But what if commercial tomato growers could coax plants into producing more fruit without sacrificing that unique and necessary bushy plant shape? Today, CSHL researchers announced that they have determined a way to accomplish this. Their research has revealed one genetic mechanism for hybrid vigor, a property of plant breeding that has been exploited to boost yield since the early 20th century. Teasing out the hidden subtleties of a type of hybrid vigor involving just one gene has provided the scientists with means to tweak the length of time that bushy tomato varieties can produce flowers. In these plants, longer flowering time substantially raises fruit yield.

First identified at CSHL by George Shull in 1908, hybrid vigor or heterosis, as biologists call it involves interbreeding genetically distinct plants to generate offspring more robust than either inbred parent. It has been used for decades to improve agricultural productivity, but scientists have long debated how and why it works.

In his previous work, CSHL Associate Professor Zach Lippman and Israeli colleagues identified a rare example of hybrid vigor involving a genetic defect in the gene that makes florigen, a hormone that controls the process of flowering and flower production. The mutation dramatically increases tomato yields in bush tomatoes, and Lippman and his team, led by postdoctoral researcher Ke Jiang, set out to understand the mechanism behind this remarkable result.

They found that bushy plants with a mutation in one of the two copies of the florigen gene, producing half as much florigen as plants without the mutation do, postpone the moment when they stop producing flowers. This, in turn, leads to many more fruits overall. "This is because," Lippman explains, "bushy tomato varieties are highly sensitive to the amount, or dosage, of the florigen hormone, which alters plant architecture that is, how many flowers can form before growth ends. These discoveries lead to an exciting prediction: that it may be possible to tweak florigen levels to increase yields even further."

Lippman's team also studied florigen mutants in another plant, the crucifer weed known as Arabidopsis that is a cousin of crops like broccoli and cauliflower. Although they did not see the same increase in yield, they did observe similar changes in plant architecture because of florigen dosage sensitivities. These results suggest that it may be possible to manipulate florigen in a wide variety of flowering species to increase yields.


'/>"/>

Contact: Jaclyn Jansen
jjansen@cshl.edu
516-367-8455
Cold Spring Harbor Laboratory
Source:Eurekalert  

Related biology news :

1. Epigenetics enigma resolved
2. Researchers complete a milestone in defining the genetic basis of rheumatoid arthritis
3. New genetic risk factor for type 2 diabetes revealed
4. Rheumatoid arthritis research shows the potential of large-scale genetic studies for drug discovery
5. Controlling parasitic worms with genetic selection
6. Significant advance reported with genetically modified poplar trees
7. Researchers engineer a hybrid 5 times more effective in delivering genetic material into cells
8. Climate change threatens genetic diversity, future of worlds caribou
9. Genetics Society of America announces recipients of spring 2014 DeLill Nasser Award
10. Environment drives genetics in Evolution Canyon; discovery sheds light on climate change
11. Eurofins scientists discover genetic differences between identical twins
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Genetic discovery points the way to much bigger yields in tomato, other flowering food plants
(Date:3/16/2017)... CeBIT 2017 - Against identity fraud with DERMALOG solutions "Made in Germany ... ... in one project, multi-biometric solutions provide a crucial contribution against identity fraud. (PRNewsFoto/Dermalog Identification Systems) ... Used combined in one project, multi-biometric solutions provide a crucial ... ...
(Date:3/7/2017)... -- Brandwatch , the leading social intelligence company, today announces ... to uncover insights to support its reporting, help direct future campaigns, ... leading youth charity will be using Brandwatch Analytics social listening and ... understanding of the topics and issues that are a priority for ... "Until ...
(Date:3/2/2017)... Summary This report provides all the information ... partnering interests and activities since 2010. Download the ... Deals and Alliance since 2010 report provides an in-depth ... world,s leading life sciences companies. On demand ... of the most up to date deal and company ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... NetworkNewsWire Editorial Coverage  ... Cancer remains one of ... health care systems, in terms of costs and resources. However, ... the development of innovative and efficient therapies that demonstrate higher ... types of cancer treatments, a growing number of patients receiving ...
(Date:3/22/2017)... , March 22, 2017 Regeneron Pharmaceuticals, Inc. ... Regeneron Genetics Center (RGC), U.K. Biobank and GSK to generate ... U.K. Biobank resource. The initiative will enable researchers to gain ... medicines for a wide range of serious and life threatening ... ...
(Date:3/22/2017)... JERUSALEM , March 22, 2017 ... ( www.oramed.com ), ... of oral drug delivery systems, announced today that ... Officer, will deliver a presentation titled, "Oral Insulin ... upcoming Cambridge Healthtech Institute,s Oligonucleotide and Peptide Therapeutics ...
(Date:3/22/2017)... , March 22, 2017   Boston Biomedical ... cancer therapeutics designed to target cancer stemness pathways, today ... S. Andrews as Chief Executive Officer, effective April ... Chiang J. Li , M.D., FACP, who has ... years ago. Under his leadership, Boston Biomedical has grown ...
Breaking Biology Technology: